Code | CSB-MP004971HU1(F2) |
Abbreviation | Recombinant Human CD96 protein, partial (Active) |
MSDS | |
Size | $138 |
Order now | |
Image | |
Have Questions? | Leave a Message or Start an on-line Chat |
Recombinant human CD96 protein was expressed with sequence Val22-Met503 of the human CD96 that was fused with a 10xHis-tag at the C-terminus in mammalian cells. Its purity is greater than 95%. Its activity and endotoxin have also been determined.
CD96 is primarily expressed by cells of hematopoietic origin, in specific on T and NK cells. CD96 plays an important role in anti-tumor immune responses and is an ideal candidate for cancer immunotherapy. It has suppressive but also activating NK cell modulating functions and is involved in the regulation of NK cell effector and metastasis. Many studies have revealed the role of the human CD96/human CD155 interaction in target cell elimination by NK cells. Human CD96 upregulation has been found in subpopulations of T-acute lymphoblastic leukemia and AML and has been associated with poor prognosis and increased resistance to chemotherapy. Human CD96 is thus a biomarker for acute myeloid leukemia stem cells (LSC) and is thus a potential target for LSC-specific therapy to treat AML.
There are currently no reviews for this product.